Tianxiang Chen

7.6k total citations · 1 hit paper
74 papers, 4.7k citations indexed

About

Tianxiang Chen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Tianxiang Chen has authored 74 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 22 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Tianxiang Chen's work include Lung Cancer Diagnosis and Treatment (22 papers), Lung Cancer Treatments and Mutations (15 papers) and Cancer-related molecular mechanisms research (9 papers). Tianxiang Chen is often cited by papers focused on Lung Cancer Diagnosis and Treatment (22 papers), Lung Cancer Treatments and Mutations (15 papers) and Cancer-related molecular mechanisms research (9 papers). Tianxiang Chen collaborates with scholars based in China, United States and United Kingdom. Tianxiang Chen's co-authors include Boxi Kang, Chenwei Li, Zemin Zhang, Zefang Tang, Xianglai Xu, Chang­hong Ren, Kunlin Jin, Brian Wang, Jiangnan Hu and Liping Xie and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Tianxiang Chen

70 papers receiving 4.7k citations

Hit Papers

GEPIA2: an enhanced web s... 2019 2026 2021 2023 2019 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianxiang Chen China 24 2.8k 1.6k 1.5k 1.1k 616 74 4.7k
Weide Zhong China 40 2.8k 1.0× 1.1k 0.7× 1.7k 1.1× 879 0.8× 490 0.8× 217 4.7k
Adrie van Bokhoven United States 35 2.5k 0.9× 1.6k 1.0× 1.1k 0.7× 992 0.9× 312 0.5× 74 4.6k
Minjiang Chen China 35 1.8k 0.6× 1.2k 0.7× 903 0.6× 1.1k 1.1× 581 0.9× 197 4.0k
Qingcai Meng China 32 2.7k 1.0× 1.3k 0.8× 1.8k 1.2× 2.1k 2.0× 1.1k 1.7× 75 4.8k
Guoping Sun China 32 2.0k 0.7× 985 0.6× 883 0.6× 974 0.9× 347 0.6× 115 4.0k
Yi‐Zhou Jiang China 40 2.8k 1.0× 1.2k 0.8× 2.1k 1.4× 2.0k 1.9× 1.2k 2.0× 167 5.9k
Roger R. Gomis Spain 30 3.4k 1.2× 889 0.6× 1.6k 1.1× 2.5k 2.4× 544 0.9× 67 6.0k
Jianping Guo China 37 3.0k 1.1× 669 0.4× 1.1k 0.8× 1.3k 1.2× 689 1.1× 124 4.8k
Sarki A. Abdulkadir United States 38 2.6k 0.9× 998 0.6× 881 0.6× 1.2k 1.2× 424 0.7× 93 4.4k
Peng Hou China 41 3.3k 1.1× 618 0.4× 1.1k 0.8× 1.3k 1.2× 429 0.7× 177 5.7k

Countries citing papers authored by Tianxiang Chen

Since Specialization
Citations

This map shows the geographic impact of Tianxiang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianxiang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianxiang Chen more than expected).

Fields of papers citing papers by Tianxiang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianxiang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianxiang Chen. The network helps show where Tianxiang Chen may publish in the future.

Co-authorship network of co-authors of Tianxiang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Tianxiang Chen. A scholar is included among the top collaborators of Tianxiang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianxiang Chen. Tianxiang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Cong-Cong, Tianxiang Chen, Xin Xu, et al.. (2025). Mitochondrial CCN1 drives ferroptosis via fatty acid β-oxidation. Developmental Cell. 60(17). 2294–2312.e11. 3 indexed citations
3.
Chen, Tianxiang, Ning Yuan, Xinling Zhang, et al.. (2024). Optimization of Controlled Low-Strength Material from Multi-Component Coal-Based Solid Waste. Sustainability. 16(4). 1513–1513. 6 indexed citations
5.
Zhao, Xinyu, Ying Li, Qinghua Ye, et al.. (2024). Advances in serum‐free media for CHO cells: From traditional serum substitutes to microbial‐derived substances. Biotechnology Journal. 19(6). e2400251–e2400251. 8 indexed citations
6.
Chen, Tianxiang, Jianfei Shen, Hui Pan, et al.. (2023). Sleeve Lobectomy After Neoadjuvant Chemoimmunotherapy Versus Chemotherapy for Squamous Cell Lung Cancer: A Multicenter, Retrospective Study. JTO Clinical and Research Reports. 4(4). 100472–100472. 3 indexed citations
7.
Sun, Xiaoyan, Tianxiang Chen, Chun Xie, et al.. (2022). Relationships between SUVmax of lung adenocarcinoma and different T stages, histological grades and pathological subtypes: a retrospective cohort study in China. BMJ Open. 12(5). e056804–e056804. 5 indexed citations
8.
Hu, Xiangyun, et al.. (2021). First Report of Alternate Hosts of Willow Rust Disease Caused by Melampsora ferrinii in China. Plant Disease. 106(1). 324–324. 4 indexed citations
9.
Shang, Jialin, Shaobo Ning, Ying‐Yi Chen, Tianxiang Chen, & Jian Zhang. (2020). MDL-800, an allosteric activator of SIRT6, suppresses proliferation and enhances EGFR-TKIs therapy in non-small cell lung cancer. Acta Pharmacologica Sinica. 42(1). 120–131. 53 indexed citations
10.
11.
Gu, Yu, Junhua Zhang, Di Liu, et al.. (2020). Metastasis Patterns and Prognosis of Octogenarians with NSCLC: A Population-based Study. Aging and Disease. 11(1). 82–82. 24 indexed citations
12.
Yang, Zhangru, Mina Liu, Jiahua Yu, et al.. (2020). Treatment of stage III non-small cell lung cancer in the era of immunotherapy: pathological complete response to neoadjuvant pembrolizumab and chemotherapy. Translational Lung Cancer Research. 9(5). 2059–2073. 11 indexed citations
13.
Tang, Zefang, Boxi Kang, Chenwei Li, Tianxiang Chen, & Zemin Zhang. (2019). GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Research. 47(W1). W556–W560. 3088 indexed citations breakdown →
14.
Wang, Yiyang, Rui Wang, Difan Zheng, et al.. (2017). The indication of completion lobectomy for lung adenocarcinoma ≤3 cm after wedge resection during surgical operation. Journal of Cancer Research and Clinical Oncology. 143(10). 2095–2104. 13 indexed citations
15.
Chen, Tianxiang, Jizhuang Luo, Rui Wang, et al.. (2017). Visceral pleural invasion predict a poor survival among lung adenocarcinoma patients with tumor size ≤ 3cm. Oncotarget. 8(39). 66576–66583. 13 indexed citations
16.
Chen, Tianxiang, Dongsheng Yan, Zhiqiang Zheng, Jiayi Yang, & Xiang Da Dong. (2017). Evolution in the surgical management of gastric cancer: is extended lymph node dissection back in vogue in the USA?. World Journal of Surgical Oncology. 15(1). 135–135. 9 indexed citations
17.
Xu, Xianglai, Brian Wang, Chang­hong Ren, et al.. (2017). Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases. Aging and Disease. 8(4). 486–486. 62 indexed citations
18.
Chen, Tianxiang, Jizhuang Luo, Haiyong Gu, et al.. (2017). Impact of Solid Minor Histologic Subtype in Postsurgical Prognosis of Stage I Lung Adenocarcinoma. The Annals of Thoracic Surgery. 105(1). 302–308. 22 indexed citations
19.
Luo, Jizhuang, Rui Wang, Baohui Han, et al.. (2016). Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma. Oncotarget. 8(4). 7050–7058. 16 indexed citations
20.
Wang, Xi, Tianxiang Chen, Lin Leng, et al.. (2012). MIF Produced by Bone Marrow–Derived Macrophages Contributes to Teratoma Progression after Embryonic Stem Cell Transplantation. Cancer Research. 72(11). 2867–2878. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026